Previous Close | 1,728.50 |
Open | 1,733.00 |
Bid | 1,650.00 x 0 |
Ask | 1,749.00 x 0 |
Day's Range | 1,718.00 - 1,743.00 |
52 Week Range | 1,302.60 - 1,743.00 |
Volume | |
Avg. Volume | 8,231,204 |
Market Cap | 70.692B |
Beta (5Y Monthly) | 0.27 |
PE Ratio (TTM) | 15.90 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 0.60 (3.47%) |
Ex-Dividend Date | May 16, 2024 |
1y Target Est | N/A |
GSK ( LON:GSK ) First Quarter 2024 Results Key Financial Results Revenue: UK£7.36b (up 5.9% from 1Q 2023). Net income...
Emma Walmsley, chief executive officer of the pharmaceutical firm hailed a ‘strong start to 2024’.
Glaxo (GSK) delivered earnings and revenue surprises of 15.96% and 3.99%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?